Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.22.2
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2022
STOCK-BASED COMPENSATION  
Schedule of Accounting for Stock-Based Compensation

Three Months Ended

Six Months Ended

June 30, 

June 30, 

    

2022

    

2021

    

2022

    

2021

Employee and director stock option grants:

 

  

 

  

 

  

 

  

Research and development

$

44,499

$

41,400

$

86,427

$

70,795

General and administrative

 

375,454

 

159,217

 

637,331

 

254,386

Total stock-based compensation

$

419,953

$

200,617

$

723,758

$

325,181

Schedule of Stock Options Activity

A summary of stock option activity is as follows:

Weighted

Number of

Average

Shares Issuable

Remaining

Upon Exercise

Weighted

Contracted

Aggregate

of Outstanding

Average

Term in

Intrinsic

    

Options

    

Exercise Price

    

Years

    

Value

Outstanding at December 31, 2021

 

423,820

$

22.70

$

Granted

 

277,850

$

5.50

Forfeited

(95,200)

$

18.60

Outstanding at March 31, 2022

606,470

$

16.40

9.03

$

Granted

62,400

$

4.69

Forfeited

 

(11,553)

$

9.09

 

 

  

Outstanding at June 30, 2022

657,317

$

15.39

8.84

$

Exercisable, June 30, 2022

 

202,264

$

28.37

7.85

$

Unvested, June 30, 2022

 

455,053

$

9.62

9.28

$